Episodios

  • Dina Kao on a trial of lyophilised sterile faecal filtrate versus lyophilised conventional donor stool for recurrent Clostridiodes difficile infection
    Nov 28 2025

    Can bacteria-free, sterile faecal filtrate match conventional faecal microbiota transplantation for recurrent C difficile infection? Dina Kao (University of Alberta) unpacks a landmark multicentre trial that tested this hypothesis, and we discuss what it tells us about the role of living organisms in the therapeutic effects of microbiota-based therapies.

    Click here to read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00190-6/fulltext

    Continue this conversation on social!

    Follow us today at...

    https://bsky.app/profile/lancetgastrohep.bsky.social

    https://www.linkedin.com/company/langastro/

    https://instagram.com/thelancetgroup

    https://facebook.com/thelancetmedicaljournal

    https://youtube.com/thelancettv

    Más Menos
    16 m
  • Premysl Bercik on a double-blind crossover trial of gluten and wheat in IBS
    Nov 20 2025

    Do wheat or gluten trigger IBS symptoms?

    We spoke to Premysl Bercik about a randomised, double-blind, sham-controlled crossover trial that challenged adults with IBS—who reported benefit from a gluten-free diet—with wheat, gluten, or a gluten-free sham to test symptom and behavioural responses.

    Click here to read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00090-1/fulltext

    Continue this conversation on social!

    Follow us today at...

    https://bsky.app/profile/lancetgastrohep.bsky.social

    https://www.linkedin.com/company/langastro/

    https://instagram.com/thelancetgroup

    https://facebook.com/thelancetmedicaljournal

    https://youtube.com/thelancettv

    Más Menos
    16 m
  • Julia Mayerle on the validation of plasma multimetabolite signatures for patients at risk of or with suspected pancreatic ductal adenocarcinoma
    Jun 19 2025

    Can a multi-metabolite blood test improve early pancreatic cancer detection? We spoke to Julia Mayerle about the METAPAC study, which sought to validate the ability of plasma metabolic signatures to find resectable tumors and reduce unnecessary invasive procedures in high-risk patients.

    Read the full article:

    https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00056-1/fulltext?dgcid=buzzsprout_icw_podcast_June_25_langas

    Continue this conversation on social!

    Follow us today at...

    https://bsky.app/profile/lancetgastrohep.bsky.social

    https://www.linkedin.com/company/langastro/

    https://instagram.com/thelancetgroup

    https://facebook.com/thelancetmedicaljournal

    https://youtube.com/thelancettv

    Más Menos
    27 m
  • Salvatore Piano on the global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis
    Apr 9 2025

    How does acute kidney injury presentation and management differ globally for patients hospitalised with cirrhosis?

    We spoke to Salvatore Piano, corresponding author of the landmark International Club of Ascites GLOBAL AKI study, about new data on regional variations in severity, phenotype, treatment, and outcomes across 5 continents.

    Read the full article:

    https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00006-8/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas

    Continue this conversation on social!

    Follow us today at...

    https://bsky.app/profile/lancetgastrohep.bsky.social

    https://www.linkedin.com/company/langastro/

    https://instagram.com/thelancetgroup

    https://facebook.com/thelancetmedicaljournal

    https://youtube.com/thelancettv

    Más Menos
    19 m
  • John Chia on the ASCOLT trial of adjuvant aspirin for colorectal cancer
    Mar 6 2025

    John Chia discusses the results of the ASCOLT trial, which explored the effect of aspirin after completion of standard adjuvant therapy for patients with colorectal cancer.

    Read the full article:

    https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00387-X/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas

    Continue this conversation on social!

    Follow us today at...

    https://bsky.app/profile/lancetgastrohep.bsky.social

    https://www.linkedin.com/company/langastro/

    https://instagram.com/thelancetgroup

    https://facebook.com/thelancetmedicaljournal

    https://youtube.com/thelancettv

    Más Menos
    13 m
  • Hannes Hagström on screening for advanced liver fibrosis alongside retina scanning in people with type 2 diabetes
    Jan 10 2025

    Hannes Hagström discusses a study investigating the feasibility of screening for advanced liver fibrosis alongside retina scanning in people with type 2 diabetes.

    Read the full article:
    https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00313-3/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas

    Continue this conversation on social!

    Follow us today at...

    https://bsky.app/profile/lancetgastrohep.bsky.social

    https://www.linkedin.com/company/langastro/

    https://instagram.com/thelancetgroup

    https://facebook.com/thelancetmedicaljournal

    https://youtube.com/thelancettv

    Más Menos
    21 m
  • Cathy Lu on intestinal ultrasound for assessing and monitoring Crohn's disease small bowel strictures
    Dec 12 2024

    Cathy Lu (University of Calgary) discusses a consensus statement on the use of intestinal ultrasound for assessing and monitoring small bowel strictures in Crohn's disease.

    Read the full article:
    https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00265-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas

    Continue this conversation on social!

    Follow us today at...

    https://bsky.app/profile/lancetgastrohep.bsky.social

    https://www.linkedin.com/company/langastro/

    https://instagram.com/thelancetgroup

    https://facebook.com/thelancetmedicaljournal

    https://youtube.com/thelancettv

    Más Menos
    11 m
  • Peter De Cruz on the PREDICT-UC trial of intensified versus standard dose infliximab for steroid-refractory acute severe ulcerative colitis
    Nov 6 2024

    Peter De Cruz (University of Melbourne) discusses the PREDICT-UC trial of intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis.

    Read the full article:
    https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00200-0?dgcid=buzzsprout_icw_podcast_generic_langas

    Continue this conversation on social!

    Follow us today at...

    https://bsky.app/profile/lancetgastrohep.bsky.social

    https://www.linkedin.com/company/langastro/

    https://instagram.com/thelancetgroup

    https://facebook.com/thelancetmedicaljournal

    https://youtube.com/thelancettv

    Más Menos
    15 m